September 16, 2014 10:35 PM ET

Healthcare Equipment and Supplies

Company Overview of InforMedix Holdings Inc.

Company Overview

InforMedix Holdings, Inc. engages in the development, patenting, and integration of Med-eXpert system, an integrated Internet-based communication system to provide data analytics; and database software platform to monitor patient medication adherence and health status. The company offers a portable patient monitoring device, hardware, software, and networked communications system to enable consumers, pharmacists, health plans, disease management organizations, pharmaceutical and biomedical companies, medical researchers, and physicians to monitor and manage patients’ medication adherence and clinical response. Its products include Med-eMonitor, a portable interactive patient monitoring ‘smar...

Georgetowne Park

5880 Hubbard Drive

Rockville, MD 20852

United States

Founded in 1997

5 Employees

Phone:

301-984-1566

Fax:

301-984-9096

Key Executives for InforMedix Holdings Inc.

Executive Chairman
Age: 64
Chief Financial Officer
Age: 65
Senior Vice President Operations and Direct Sales and Director of Sales
Age: 56
Vice President of Research & Development and Vice President of Research & Development - InforMedix Inc
Age: 60
Senior Vice President
Compensation as of Fiscal Year 2014.

InforMedix Holdings Inc. Key Developments

SEC Orders Hearings On Registration Suspension Or Revocation Against InforMedix Holdings

In conjunction with trading suspension, the Securities and Exchange Commission (SEC or the Commission) also instituted public administrative proceedings to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of InforMedix Holdings, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company delinquent in their required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceedings.

Similar Private Companies By Industry

Company Name Region
KBco, The Polarized Lens Company United States
Boston Brace International, Inc. United States
Biorasis Inc. United States
ColoWrap, LLC United States
Arges Imaging, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InforMedix Holdings Inc., please visit www.informedix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.